Peter Vorhees, MD Director of Outreach and Clinical Operations, Department of Hematologic Oncology and Blood Diosrders, Levine Cancer Institute, discusses What Regimens Are Being Used For MM Patients Today. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
